Insulin patents and market exclusivities: unresolved issues

Kaplan, Warren; Laing, Richard; Ewen, Marg; Beran, David Henri

doi:10.1016/S2213-8587(15)00496-9

Scientific article

Comment

English

Insulin patents and market exclusivities: unresolved issues

ContributorsKaplan, Warren; Laing, Richard; Ewen, Marg; Beran, David Henri

Published inThe Lancet Diabetes & Endocrinology, vol. 4, no. 2, 98

Publication date2016

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

Citation (ISO format)

KAPLAN, Warren et al. Insulin patents and market exclusivities: unresolved issues. In: The Lancet Diabetes & Endocrinology, 2016, vol. 4, n° 2, p. 98. doi: 10.1016/S2213-8587(15)00496-9

Article (Published version)

Identifiers

PID : unige:144230
DOI : 10.1016/S2213-8587(15)00496-9
PMID : 26825233

Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S2213858715004969

Journal ISSN2213-8587

183views

0downloads

Creation13/10/2020 00:52:00

First validation13/10/2020 00:52:00

Update time15/03/2023 23:58:53

Status update15/03/2023 23:58:52

Last indexation31/10/2024 21:14:19

Archive ouverte UNIGE

Insulin patents and market exclusivities: unresolved issues

Technical informations